---

Open Letter to Polish Parliamentarians on NaProTechnology

As infertility treatment professionals participating in the international conference "NaProTechnology - Lublin 2009", we would like to announce the launch of a revolutional womens' reproductive health science known as NaProTechnology in Poland.

This science allows for an in-depth evaluation and effective treatment of the causes of infertility. It gives couples the chance to conceive a child through natural sexual relations and to bear a healthy child to term and give birth to it. For that purpose, this science applies the latest achievements of many branches of medicine, including surgery, gynecology, pharmacology and andrology, in full ecological cooperation with the woman's natural reproductive physiology.

The experience of our colleagues from the US and Ireland proves that NaProTechnology is more effective than IVF. It also offers solutions in cases when IVF fails or is highly risky. NaProTechnology can also often overcome the problem of male infertility.

At the same time, NaProTechnology offers a comprehensive, holistic approach to women's reproductive health. In an unprecedented way it can predict fertility problems, such as risk of miscarriage, as well as a patient's inclination to other diseases, including, for example, breast cancer. NaProTechnology is effective in treating endometriosis, PMS, recurrent ovarian cysts, post-natal depression and other irregularities, without risking the side effects of other pharmaceutical therapies which are  harmful to natural physiology.

Moreover, the Creighton Model System - a biomarker observation method built into NaProTechnology - allows for effective family planning without incurring any of the problems and risks connected to hormonal contraception and IUDs.

As a diagnostic-therapeutical method, NaProTechnology constitutes a cheap, realistic, healthy and wholly ethical alternative to artificial reproduction. It is already present in many countries, including Poland. The NaProTechnology 2009 conference in Lublin testified to a growing interest in NaProTechnology among medical professionals and patients. Hundreds of participants from Poland and abroad listened to presentations by scientists from the US, Ireland and Canada. Interns, doctors and Creighton Model instructors also underwent further professional training.

We would like to emphasize the fact that contrary to NaProTechnology, artificial fertilization entails risk of embryo death, miscarriage and multiple pregnancies oftentimes resulting in premature births. IVF also incurs increased risk of fetal abnormalities and of health issues for the woman undergoing ovarian hyperstimulation. It violates the dignity of men, women and children.

IVF is an expensive, less effective, controversial method that entails serious health risks. It is no wonder that around the world, only a small percentage of couples struggling with infertility decide to undergo IVF. NaProTechnology offers everyone an unquestioned new alternative.

We ask you to consider all these facts in the debate on infertility treatment which is now underway and to take NaProTechnology into account in public discourse. We also ask you to vote to reject all legislative proposals to legalize IVF or to allow for public funding of ARTs which  would thereby not only force our society to accept IVF, but would also promote the erroneous view of IVF as the single most effective possible answer to infertility.

 Back to Top

---

MORE NEWS: LifeSiteNews.com Home Page  Last 10 Days   Archives   Special Reports

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.